NASDAQ:NBIX - Nasdaq - US64125C1099 - Common Stock - Currency: USD
We assign a fundamental rating of 7 out of 10 to NBIX. NBIX was compared to 560 industry peers in the Biotechnology industry. NBIX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. NBIX is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make NBIX suitable for growth and quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.18% | ||
ROE | 13.18% | ||
ROIC | 13.2% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 24.75% | ||
PM (TTM) | 14.49% | ||
GM | 98.56% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 7.88 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 3.4 | ||
Quick Ratio | 3.28 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 41.33 | ||
Fwd PE | 18.99 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 21.66 | ||
EV/EBITDA | 14.97 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:NBIX (5/27/2025, 2:58:00 PM)
121.92
+1.74 (+1.45%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 41.33 | ||
Fwd PE | 18.99 | ||
P/S | 5.12 | ||
P/FCF | 21.66 | ||
P/OCF | 20.27 | ||
P/B | 4.66 | ||
P/tB | 4.73 | ||
EV/EBITDA | 14.97 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.18% | ||
ROE | 13.18% | ||
ROCE | 18.16% | ||
ROIC | 13.2% | ||
ROICexc | 32.81% | ||
ROICexgc | 33.77% | ||
OM | 24.75% | ||
PM (TTM) | 14.49% | ||
GM | 98.56% | ||
FCFM | 23.66% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | 0 | ||
Cap/Depr | 140.96% | ||
Cap/Sales | 1.62% | ||
Interest Coverage | 364.38 | ||
Cash Conversion | 97.59% | ||
Profit Quality | 163.26% | ||
Current Ratio | 3.4 | ||
Quick Ratio | 3.28 | ||
Altman-Z | 7.88 |